Aurobindo Pharma Ltd Board of Directors

Home

Insights

Board of Directors

₹ 1.4 Cr

Volume transacted

9.4 K

stocks traded

Last Updated time: 19 Sep 9.00 AM

Board of Directors

Name	Designation

Kambam Nityananda Reddy	Vice Chairman & M.D.
M Madan Mohan Reddy	Whole-time Director
P V Ramprasad Reddy	Non Executive Director
Savita Mahajan	Independent Director
Girish Paman Vanvari	Independent Director

name	designation
Kambam Nityananda Reddy	Vice Chairman & M.D.
M Madan Mohan Reddy	Whole-time Director
P V Ramprasad Reddy	Non Executive Director
Savita Mahajan	Independent Director
Girish Paman Vanvari	Independent Director

Open Demat Account

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Key Highlights

Kambam Nityananda Reddy joins the board as Vice Chairman & M.D., in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
M Madan Mohan Reddy joins the board as Whole-time Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
P V Ramprasad Reddy continues to serve as the Non Executive Director in 2024, maintaining the same position as in the previous year.
Savita Mahajan joins the board as Independent Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Girish Paman Vanvari joins the board as Independent Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.

Aurobindo Pharma Ltd

NSE: AUROPHARMA

PRICE

Last updated:

Last Ten Days Share Price

Date	Price	Day Open	Day High	Day Low

19 Sep 2024	1527.35	1550	1560.3	1511.55
18 Sep 2024	1538.75	1556.5	1556.5	1519.55
17 Sep 2024	1552.05	1552.5	1567.25	1550
16 Sep 2024	1562.1	1568.95	1583	1551
13 Sep 2024	1567.6	1568.8	1592.55	1555.55
12 Sep 2024	1560.2	1517.3	1577.95	1517.3
11 Sep 2024	1507.2	1529	1545.1	1502.9
10 Sep 2024	1518.45	1523.45	1534.25	1515.85
09 Sep 2024	1518.35	1532.25	1538.5	1513.65
06 Sep 2024	1538.5	1563.25	1563.25	1516.25

Date	Price
19 Sep 2024	1527.35
18 Sep 2024	1538.75
17 Sep 2024	1552.05
16 Sep 2024	1562.1
13 Sep 2024	1567.6
12 Sep 2024	1560.2
11 Sep 2024	1507.2
10 Sep 2024	1518.45
09 Sep 2024	1518.35
06 Sep 2024	1538.5

Company Fundamentals for Aurobindo Pharma Ltd

Market Cap

₹ 89,493 Cr

EPS

₹ 61.2

P/E Ratio (TTM) *

25.0

P/B Ratio (TTM) *

3.0

Day’s High *

1560.3

Day’s Low

₹ 1511.55

DTE *

0.2

ROE *

10.6

52 Week High

₹ 1592.55

52 Week Low

₹ 834.9

ROCE *

12.8

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

Monitoring Aurobindo Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Aurobindo Pharma Ltd News Hub

Eugia Steriles receives concludes UFDA inspection of its new injectable facility

Aurobindo Pharma announced that the USFDA has issued the Establishment Inspection Report f...

18 Sep 202411:02

Auro Pharma arm gets EIR from USFDA for AP facility

The United States Food and Drug Administration (USFDA) had conducted a pre-approval inspec...

18 Sep 202412:07

Aurobindo Pharma arm gets USFDA nod for anesthetic drug

Lidocaine is a local anesthetic (numbing medication) that is used to numb an area of your ...

11 Sep 202412:26

Eugia Steriles receives its first product approval from USFDA for Lidocaine Hydrochloride Injection

Aurobindo Pharma announced that the new injectable facility of Eugia Steriles (a 100% subs...

11 Sep 202412:15

Aurobindo Pharma Ltd up for fifth session

Aurobindo Pharma Ltd is up for a fifth straight session in a row. The stock is quoting at ...

28 Aug 202413:00

Eugia Pharma Specialities receives USFDA warning for Unit III

Aurobindo Pharma announced that the USFDA has issued a warning letter for Unit-III of Eugi...

16 Aug 202410:06

Document

Annual Reports

Annual Report 2024

Credit Ratings

Credit Report 2024

Concalls

May 2024

Feb 2024

Nov 2023

Aug 2023

June 2023

Feb 2023

Nov 2022

Aug 2022

June 2022

Feb 2022

Nov 2021

Sep 2021

Aug 2021

June 2021

Feb 2021

Nov 2020

Aug 2020

June 2020

Feb 2020

Jan 2020

May 2024

Feb 2024

Nov 2023

Aug 2023

June 2023

Feb 2023

Nov 2022

Aug 2022

June 2022

Feb 2022

Nov 2021

Sep 2021

Aug 2021

June 2021

Feb 2021

Nov 2020

Aug 2020

June 2020

Feb 2020

Jan 2020

Aurobindo Pharma Ltd market cap

Aurobindo Pharma Ltd share price history

Aurobindo Pharma Ltd isin code

Sun Pharmaceuticals Industries Ltd board of directors

Divis Laboratories Ltd board of directors

Cipla Ltd board of directors

Torrent Pharmaceuticals Ltd board of directors

Dr Reddys Laboratories Ltd board of directors

Zydus Lifesciences Ltd board of directors

Lupin Ltd board of directors

Mankind Pharma Ltd board of directors

Alkem Laboratories Ltd board of directors

Abbott India Ltd board of directors

FAQs for Board of Directors of Aurobindo Pharma Ltd

How are members of Aurobindo Pharma Ltd Board of Directors selected?

Members of the Aurobindo Pharma Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Aurobindo Pharma Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.

Can shareholders interact with the Aurobindo Pharma Ltd Board of Directors?

Shareholders can interact with the Aurobindo Pharma Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.

How often does the Aurobindo Pharma Ltd Board of Directors meet?

The Aurobindo Pharma Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.

What are the responsibilities of the Aurobindo Pharma Ltd Board of Directors?

The Aurobindo Pharma Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.

Who are the current members of the Board of Directors at Aurobindo Pharma Ltd?

The current Board of Directors at Aurobindo Pharma Ltd includes Kambam Nityananda Reddy( Vice Chairman & M.D.) ,M Madan Mohan Reddy( Whole-time Director) ,P V Ramprasad Reddy( Non Executive Director) ,Savita Mahajan( Independent Director) ,Girish Paman Vanvari( Independent Director) . The full list can be found on Aurobindo Pharma Ltd’s official website or recent corporate filings.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Unlimited trading at just

~~Rs. 399~~

Rs. 199*

Aurobindo Pharma Ltd Board of Directors

Board of Directors

Key Highlights

Last Ten Days Share Price

Company Fundamentals for Aurobindo Pharma Ltd

PRICE

Share price Over Time

Aurobindo Pharma Ltd News Hub

Document

Popular Search